Jie Min Luo
Directeur Général chez AMOY DIAGNOSTICS CO., LTD.
Postes actifs de Jie Min Luo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AMOY DIAGNOSTICS CO., LTD. | Directeur/Membre du Conseil | 13/08/2021 | - |
| Directeur Général | 01/12/2021 | - | |
| Investor Relations Contact | 18/06/2015 | - | |
| Secrétaire Général | 18/06/2015 | 01/12/2021 | |
SinoPath Medical Investment (Beijing) Co., Ltd.
 SinoPath Medical Investment (Beijing) Co., Ltd. Medical/Nursing ServicesHealth Services SinoPath Medical Investment (Beijing) Co., Ltd. engages in the third-party medical diagnostic genetics laboratory. It provides clinical genetic testing, consultation, and advisory services. Its products include cancer detection, remote pathology consultation, hereditary cancer detection, hereditary cardiovascular disease testing, single-gene genetic disease detection, susceptibility gene examination, and immunohistochemistry. The company was founded on June 30, 2013 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Jie Min Luo
Statistiques
Internationale
| Chine | 3 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Investor Relations Contact | 1 |
Sectorielle
| Health Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMOY DIAGNOSTICS CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
SinoPath Medical Investment (Beijing) Co., Ltd.
SinoPath Medical Investment (Beijing) Co., Ltd. Medical/Nursing ServicesHealth Services SinoPath Medical Investment (Beijing) Co., Ltd. engages in the third-party medical diagnostic genetics laboratory. It provides clinical genetic testing, consultation, and advisory services. Its products include cancer detection, remote pathology consultation, hereditary cancer detection, hereditary cardiovascular disease testing, single-gene genetic disease detection, susceptibility gene examination, and immunohistochemistry. The company was founded on June 30, 2013 and is headquartered in Beijing, China. | Health Services |
- Bourse
- Insiders
- Jie Min Luo
- Expérience
